Combined Androgen Blockade in the Treatment of Advanced Prostatic Cancer – An overview.

Iversen, P. on behalf of the Scandinavian Prostatic Cancer Group.

Scand J Urol Nephrol. 1997


The value of combined androgen blockade in the treatment of patients with advanced prostate cancer is still controversial. In this review by the Scandinavian Prostatic Cancer Group, the literature addressing the concept and its clinical use is critically reviewed.